C. Mandara

发表

Describing the current status of Plasmodium falciparum population structure and drug resistance within mainland Tanzania using molecular inversion probes

J. Bailey, R. Verity, O. Watson, 2020, Molecular ecology.

High efficacy of artemether–lumefantrine and dihydroartemisinin–piperaquine for the treatment of uncomplicated falciparum malaria in Muheza and Kigoma Districts, Tanzania

M. Lemnge, J. Mghamba, R. Njau, 2018, Malaria Journal.

Potential Opportunities and Challenges of Deploying Next Generation Sequencing and CRISPR-Cas Systems to Support Diagnostics and Surveillance Towards Malaria Control and Elimination in Africa

J. Bailey, J. Cunningham, J. Juliano, 2022, Frontiers in Cellular and Infection Microbiology.

Acceptability of malaria rapid diagnostic tests administered by village health workers in Pangani District, North eastern Tanzania

M. Lemnge, Filbert Francis, J. Schellenberg, 2016, Malaria Journal.

TITLE PAGE Title: Describing the current status of Plasmodium falciparum population structure and drug resistance within mainland Tanzania using molecular inversion probes Major/Minor Category: Biological Sciences/Genetics Authors and Affiliations: Kara

J. Bailey, R. Verity, O. Watson, 2022 .

Capacity Development through the US President’s Malaria Initiative–Supported Antimalarial Resistance Monitoring in Africa Network

D. Ndiaye, S. Kariuki, B. Hamainza, 2017, Emerging infectious diseases.

High cure rates and tolerability of artesunate–amodiaquine and dihydroartemisinin–piperaquine for the treatment of uncomplicated falciparum malaria in Kibaha and Kigoma, Tanzania

B. Ngasala, R. Njau, D. Ishengoma, 2019, Malaria Journal.

Performance of health laboratories in provision of HIV diagnostic and supportive services in selected districts of Tanzania

M. Lemnge, L. Mboera, S. Magesa, 2017, BMC Health Services Research.

Referral success among HIV-infected women and HIV-exposed children referred for monitoring and treatment in Tanga, Tanzania.

M. Lemnge, J. Gerstoft, C. Mandara, 2010, International health.

Performance of antigen detection for HRP2-based malaria rapid diagnostic tests in community surveys: Tanzania, July–November 2017

R. Njau, D. Ishengoma, M. Pluciński, 2022, Malaria Journal.

Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria and prevalence of Pfk13 and Pfmdr1 polymorphisms after a decade of using artemisinin-based combination therapy in mainland Tanzania

B. Ngasala, N. Lucchi, R. Njau, 2019, Malaria Journal.

Community-based surveys for Plasmodium falciparum pfhrp2 and pfhrp3 gene deletions in selected regions of mainland Tanzania

R. Njau, D. Ishengoma, S. Nyanjom, 2020, Malaria Journal.

B. Ngasala, N. Lucchi, R. Njau, 2019, Malaria Journal.

Pf7: an open dataset of Plasmodium falciparum genome variation in 20,000 worldwide samples

Diego F. Echeverry, J. Rayner, D. Conway, 2023, Wellcome open research.

High efficacy of artemether–lumefantrine and dihydroartemisinin–piperaquine for the treatment of uncomplicated falciparum malaria in Muheza and Kigoma Districts, Tanzania

M. Lemnge, J. Mghamba, R. Njau, 2018, Malaria journal.

Therapeutic efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in North-Eastern Tanzania

M. Lemnge, J. Buza, D. Ishengoma, 2014, Malaria Journal.

Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania

M. Lemnge, D. Ménard, B. Ngasala, 2018, Malaria Journal.

Trends of Plasmodium falciparum prevalence in two communities of Muheza district North-eastern Tanzania: correlation between parasite prevalence, malaria interventions and rainfall in the context of re-emergence of malaria after two decades of progressively declining transmission

R. Snow, M. Lemnge, I. Bygbjerg, 2018, Malaria Journal.

Implementation research of a cluster randomized trial evaluating the implementation and effectiveness of intermittent preventive treatment for malaria using dihydroartemisinin-piperaquine on reducing malaria burden in school-aged children in Tanzania: methodology, challenges, and mitigation

J. Lusingu, S. Gesase, E. Liheluka, 2023, Malaria Journal.

Pattern of all-causes and cause-specific mortality in an area with progressively declining malaria burden in Korogwe district, north-eastern Tanzania

O. Abdul, M. Lemnge, D. Ishengoma, 2018, Malaria Journal.

Community knowledge, attitudes and practices towards tuberculosis and its treatment in Mpwapwa district, central Tanzania.

P. Mangesho, W. Makunde, C. Mandara, 2007, Tanzania health research bulletin.

Lost to follow up and clinical outcomes of HIV adult patients on antiretroviral therapy in care and treatment centres in Tanga City, north-eastern Tanzania.

H. Msangeni, B. Mmbando, Filbert Francis, 2012, Tanzania journal of health research.

R. Snow, M. Lemnge, I. Bygbjerg, 2018, Malaria Journal.

The readiness of the national health laboratory system in supporting care and treatment of HIV/AIDS in Tanzania

L. Mboera, S. Magesa, D. Ishengoma, 2015, BMC Health Services Research.

Therapeutic efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in

M. Lemnge, J. Buza, D. Ishengoma, 2014 .

Assessing the intrinsic and extrinsic drivers and targeting the observed resilience of malaria in northwestern and southern Tanzania: A protocol for a cross-sectional exploratory study

E. Liheluka, Y. A. Derua, R. Njau, 2020, medRxiv.

Supply chain management of laboratory supportive services and its potential implications on the quality of HIV diagnostic services in Tanzania

M. Lemnge, L. Mboera, S. Magesa, 2018 .

Pattern of all-causes and cause-specific mortality in an area with progressively declining malaria burden in Korogwe district, north-eastern Tanzania

O. Abdul, M. Lemnge, D. Ishengoma, 2018, Malaria Journal.

Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania

M. Lemnge, D. Ménard, B. Ngasala, 2018, Malaria Journal.

High cure rates and tolerability of artesunate–amodiaquine and dihydroartemisinin–piperaquine for the treatment of uncomplicated falciparum malaria in Kibaha and Kigoma, Tanzania

B. Ngasala, R. Njau, D. Ishengoma, 2019, Malaria Journal.

Genetic polymorphism and evidence of signatures of selection in the Plasmodium falciparum circumsporozoite protein gene in Tanzanian regions with different malaria endemicity

D. Ishengoma, C. Mandara, D. Pereus, 2024, Malaria journal.

Evidence of artemisinin partial resistance in northwestern Tanzania: clinical and molecular markers of resistance.

D. Ishengoma, C. Mandara, M. Warsame, 2024, The Lancet. Infectious diseases.

Evidence of artemisinin partial resistance in North-western Tanzania: clinical and drug resistance markers study

D. Ishengoma, C. Mandara, M. Warsame, 2024, medRxiv.

Microsatellites reveal high polymorphism and high potential for use in anti-malarial efficacy studies in areas with different transmission intensities in mainland Tanzania

R. Njau, D. Ishengoma, R. Kavishe, 2023, medRxiv.

Prevalence of mutations associated with artemisinin partial resistance and sulfadoxine-pyrimethamine resistance in 13 regions in Tanzania in 2021: a cross-sectional survey.

D. Ishengoma, C. Mandara, F. Molteni, 2024, The Lancet. Microbe.

High frequency of artemisinin partial resistance mutations in the great lake region revealed through rapid pooled deep sequencing

C. Karema, D. Ishengoma, J. Mazarati, 2024, medRxiv.

Country wide surveillance reveals prevalent artemisinin partial resistance mutations with evidence for multiple origins and expansion of high level sulfadoxine-pyrimethamine resistance mutations in northwest Tanzania

R. Njau, D. Ishengoma, C. Mandara, 2023, medRxiv.

Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in mainland Tanzania, 2019

B. Ngasala, D. Ishengoma, B. Mmbando, 2024, Malaria journal.

Trends of Plasmodium falciparum molecular markers associated with resistance to artemisinins and reduced susceptibility to lumefantrine in Mainland Tanzania from 2016 to 2021

B. Ngasala, N. Lucchi, D. Ishengoma, 2024, bioRxiv.